RIG
55
-6
PYPL
56
-4
MSFT
57
6
ADBE
61
11
SRE
45
-9
JWN
59
2
GOOG
57
2
KO
47
-2
WU
34
-2
TSN
42
3
EXPD
48
-5
WAT
64
7
EMC
56
-3
SIG
50
-5
SNA
65
-3
ABBV
50
8
BWA
48
-5
UA
57
-8
LB
60
4
DHR
41
2
RIG
55
-6
PYPL
56
-4
MSFT
57
6
ADBE
61
11
SRE
45
-9
JWN
59
2
GOOG
57
2
KO
47
-2
WU
34
-2
TSN
42
3
EXPD
48
-5
WAT
64
7
EMC
56
-3
SIG
50
-5
SNA
65
-3
ABBV
50
8
BWA
48
-5
UA
57
-8
LB
60
4
DHR
41
2
Financhill
Back

Revance Therapeutics Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
17

RVNC
Revance Therapeutics

Last Price:
3.90
Seasonality Move:
6.97%

7 Day Trial

ALL ACCESS PASS

$ 7

Trade on Tuesday. Profit on Friday. Rinse & Repeat

Get the full details now.

Revance Therapeutics Price Quote

$3.90
-0.12 (-2.99%)
(Updated: November 27, 2024 at 2:35 PM ET)

Revance Therapeutics Key Stats

Sell
17
Revance Therapeutics (RVNC) is a Sell
Day range:
$3.87 - $4.20
52-week range:
$2.30 - $9.75
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.51
P/B ratio:
0%
Volume:
2.2M
Avg. volume:
2.4M
1-year change:
-44.17%
Market cap:
$421.7M
Revenue:
$234M
EPS:
$-1.94

How Much Does Revance Therapeutics Make?

Is Revance Therapeutics Growing As A Company?

  • What Is Revance Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.11%
  • What Is Revance Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Revance Therapeutics Stock Price Performance

What Is Revance Therapeutics 52-Week High & Low?

Revance Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Revance Therapeutics?

Is Revance Therapeutics Cash Flow Positive?

  • What Is RVNC Cash Flow From Operations?
    Cash flow from operations (TTM) is -$190.9M
  • What Is Revance Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $81.7M
  • What Is Revance Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$12.9M

Revance Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    RVNC return on invested capital is -61.49%
  • What Is Revance Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -37.25%
  • What Is RVNC Return On Equity?
    ROE is a measure of profitability and is 0%

Revance Therapeutics Earnings Date & Stock Price

Revance Therapeutics Competitors

Revance Therapeutics Dividend Yield

Revance Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 6.33%
Revenue: 10.66% -12.17%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 8
Sell Recommendations: 0
Price Target: 9.23
Upside from Last Price: 129.5%

Major Shareholders

  • How many RVNC shares are owned by institutional investors?
    112.6M RVNC shares are owned by institutional investors
  • How many RVNC shares are owned by insiders?
    2.7M RVNC shares are owned by insiders